Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Cipla
Accenture
Citi
Cantor Fitzgerald
McKesson
Baxter
AstraZeneca
Deloitte

Generated: June 24, 2018

DrugPatentWatch Database Preview

Abbott Company Profile

« Back to Dashboard

What is the competitive landscape for ABBOTT, and what generic and branded alternatives to ABBOTT drugs are available?

ABBOTT has one hundred and fourteen approved drugs.



Summary for Abbott
US Patents:0
Tradenames:92
Ingredients:65
NDAs:114
Patent Litigation for Abbott: See patent lawsuits for Abbott

Drugs and US Patents for Abbott

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbott HYTRIN terazosin hydrochloride CAPSULE;ORAL 020347-001 Dec 14, 1994 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial
Abbott MERIDIA sibutramine hydrochloride CAPSULE;ORAL 020632-001 Nov 22, 1997 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Abbott DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER dextrose; sodium chloride INJECTABLE;INJECTION 019483-001 Oct 4, 1985 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Abbott VERCYTE pipobroman TABLET;ORAL 016245-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for Abbott

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Abbott HYTRIN terazosin hydrochloride CAPSULE;ORAL 020347-001 Dec 14, 1994 5,412,095 ➤ Try a Free Trial
Abbott HYTRIN terazosin hydrochloride TABLET;ORAL 019057-002 Aug 7, 1987 4,112,097 ➤ Try a Free Trial
Abbott HYTRIN terazosin hydrochloride TABLET;ORAL 019057-003 Aug 7, 1987 5,212,176 ➤ Try a Free Trial
Abbott HYTRIN terazosin hydrochloride TABLET;ORAL 019057-003 Aug 7, 1987 5,412,095 ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Paragraph IV (Patent) Challenges for ABBOTT drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Capsules 10 mg and 15 mg ➤ Subscribe 2009-08-14
➤ Subscribe Capsules 100 mg ➤ Subscribe 2012-10-31
➤ Subscribe Tablets 100 mg ➤ Subscribe 2010-12-21
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Cantor Fitzgerald
Colorcon
Argus Health
Mallinckrodt
Dow
Medtronic
Boehringer Ingelheim
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.